GO:0004955 prostaglandin receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004955 prostaglandin receptor activity describes the molecular function of combining with a prostaglandin (PG) to initiate a change in cell activity.
• Prostaglandin receptors are G protein-coupled receptors (GPCRs) that mediate diverse physiological and pathological responses, including inflammation, pain, and immune regulation.
• Key prostaglandin receptors include DP1 (PTGDR), DP2 (CRTH2), EP4 (PTGER4), and others, each with distinct ligand selectivity and signaling pathways.
• Dysregulated prostaglandin receptor activity is implicated in diseases such as ankylosing spondylitis, airway inflammation, and acute ischemic heart disease.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise interrogation of prostaglandin receptor function and drug discovery.
• EDITGENE provides comprehensive CRISPR services to accelerate research on prostaglandin receptor activity and related pathways.
Description
Prostaglandin receptor activity (GO:0004955) is a molecular function defined as the binding of a prostaglandin (PG) molecule to a receptor, leading to a change in cell activity. Prostaglandins are lipid mediators derived from arachidonic acid and exert autocrine and paracrine effects through specific G protein-coupled receptors (GPCRs). This activity is fundamental to numerous physiological processes, including inflammation, pain perception, immune modulation, and cardiovascular homeostasis. Research into prostaglandin receptor activity has revealed its critical roles in both health and disease. For instance, the DP1 receptor (PTGDR) mediates prostaglandin D2 signaling and is a target for anti-inflammatory therapies. The EP4 receptor (PTGER4) is associated with high disease activity in ankylosing spondylitis. Additionally, impaired prostaglandin E1/I2 receptor activity has been observed in acute ischemic heart disease. Understanding the molecular mechanisms and regulatory networks of prostaglandin receptors is essential for developing targeted therapeutics. This article provides a comprehensive overview of GO:0004955, covering its definition, biological significance, key genes, research methodologies, and disease associations. It is intended for researchers seeking to study prostaglandin receptor activity using advanced CRISPR-based models and other experimental approaches.
prostaglandin receptor activity At A Glance
| GO ID | GO:0004955 |
|---|---|
| GO term | prostaglandin receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to prostaglandins to initiate changes in cell activity, typically via G protein-coupled receptor signaling. |
| Major receptors | DP1 (PTGDR), DP2 (CRTH2), EP1-EP4 (PTGER1-4), FP (PTGFR), IP (PTGIR), TP (TBXA2R). |
| Signaling pathways | Gs, Gi, Gq, and β-arrestin pathways, leading to cAMP modulation, calcium mobilization, and kinase activation. |
| Disease relevance | Inflammation, asthma, ankylosing spondylitis, cardiovascular disease, and autoimmune conditions. |
What Is GO:0004955?
Prostaglandin receptor activity (GO:0004955) is the molecular function of combining with a prostaglandin (PG) to initiate a change in cell activity. This activity is mediated by specific cell surface receptors that bind prostaglandins such as PGD2, PGE2, PGF2α, PGI2, and TXA2, and transduce signals into cellular responses.
Why Is prostaglandin receptor activity Important in Cell Biology?
Prostaglandin receptor activity is crucial because it mediates the diverse and potent effects of prostaglandins, which are key lipid mediators in inflammation, immunity, and cardiovascular function. Dysregulation of these receptors contributes to numerous diseases, making them attractive drug targets. Understanding their activity at the molecular level informs the development of selective agonists and antagonists for therapeutic intervention.
• Mediates inflammatory responses and pain signaling, making it a target for anti-inflammatory drugs.
• Regulates immune cell functions, including Th17 cell activity in ankylosing spondylitis.
• Involved in airway inflammation and asthma, with DP2 antagonists like fevipiprant in clinical trials.
• Plays a role in cardiovascular homeostasis; impaired receptor activity is linked to acute ischemic heart disease.
• Modulates CFTR activity in airway epithelium via prostaglandin signaling.
• Contributes to autoimmune neuroinflammation through CRTH2 on B cells.
• Provides opportunities for CRISPR-based functional genomics and drug discovery.
• Essential for understanding GPCR pharmacology and biased signaling.
• Potential biomarker for disease activity and therapeutic response.
• Enables development of precision medicine approaches targeting specific receptor subtypes.
What Happens During prostaglandin receptor activity?
Ligand Binding and Receptor Activation
In simple terms: A prostaglandin molecule binds to its specific receptor on the cell surface, like a key fitting into a lock.
Prostaglandin receptors are activated by the binding of specific prostaglandins (e.g., PGD2, PGE2) to their extracellular domains. Structural studies of the DP1 receptor reveal that ligand binding induces conformational changes in the transmembrane helices, leading to receptor activation. This activation is highly selective, with distinct residues determining ligand specificity.
G Protein Coupling and Second Messenger Generation
In simple terms: Once activated, the receptor interacts with G proteins inside the cell, triggering the production of signaling molecules.
Activated prostaglandin receptors couple to heterotrimeric G proteins (Gs, Gi, Gq). For example, DP1 couples to Gs, stimulating adenylyl cyclase and increasing cAMP levels. EP4 also signals via Gs, while other receptors may couple to Gi or Gq, leading to diverse downstream effects.
Downstream Signaling Cascades
In simple terms: The second messengers then activate various proteins that change cell behavior.
Elevated cAMP activates protein kinase A (PKA), which phosphorylates target proteins, including CFTR, thereby regulating ion transport. Other pathways involve calcium mobilization and MAPK activation, as seen with CRTH2 (DP2) signaling through p38 in B cells. These cascades ultimately modulate gene expression, cell proliferation, and immune responses.
Receptor Desensitization and Internalization
In simple terms: After signaling, the receptor is turned off and brought inside the cell to prevent overstimulation.
Prolonged agonist exposure leads to receptor phosphorylation by G protein-coupled receptor kinases (GRKs) and recruitment of β-arrestins, which desensitize the receptor and promote internalization. This process is critical for maintaining cellular responsiveness and is a target for pharmacological intervention.
Key Genes Involved in GO:0004955 prostaglandin receptor activity
The following genes encode the major prostaglandin receptors and related proteins involved in prostaglandin receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTGDR | DP1 receptor for PGD2; couples to Gs | Target for allergic inflammation; structural studies |
| PTGDR2 | DP2 (CRTH2) receptor for PGD2; couples to Gi | Mediates Th2 inflammation; target for fevipiprant |
| PTGER1 | EP1 receptor for PGE2; couples to Gq | Involved in pain and fever |
| PTGER2 | EP2 receptor for PGE2; couples to Gs | Regulates ovulation and inflammation |
| PTGER3 | EP3 receptor for PGE2; couples to Gi | Modulates gastric acid secretion |
| PTGER4 | EP4 receptor for PGE2; couples to Gs | Associated with ankylosing spondylitis |
| PTGFR | FP receptor for PGF2α; couples to Gq | Regulates uterine contraction |
| PTGIR | IP receptor for PGI2; couples to Gs | Vasodilation and platelet inhibition |
| TBXA2R | TP receptor for TXA2; couples to Gq | Platelet aggregation and vasoconstriction |
| GNA S | Gs alpha subunit | Mediates cAMP signaling |
| GNAI1 | Gi alpha subunit | Inhibits adenylyl cyclase |
| GNAQ | Gq alpha subunit | Activates phospholipase C |
| ARRB1 | β-arrestin 1 | Receptor desensitization |
| ARRB2 | β-arrestin 2 | Receptor internalization |
| CFTR | Chloride channel | Activated by prostaglandin signaling |
| CRTH2 | DP2 receptor | B cell function in EAE |
| PTGS1 | Cyclooxygenase-1 | Prostaglandin synthesis |
| PTGS2 | Cyclooxygenase-2 | Inducible prostaglandin synthesis |
How Is prostaglandin receptor activity Regulated?
Prostaglandin receptor activity is regulated at multiple levels. Receptor expression is modulated by inflammatory cytokines and growth factors. Desensitization and internalization are controlled by GRK-mediated phosphorylation and β-arrestin recruitment. Additionally, prostaglandin synthesis by cyclooxygenases (PTGS1/2) affects ligand availability. Cross-talk with other signaling pathways, such as p38 MAPK, further fine-tunes receptor responses.
prostaglandin receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTGER4 | Ankylosing spondylitis | Knockout mice or human Th17 cell cultures |
| CRTH2 | Multiple sclerosis (EAE model) | CRTH2 knockout mice |
| PTGIR | Acute ischemic heart disease | Platelet-specific knockout or point mutation |
| PTGDR | Allergic asthma | Knock-in mice expressing human DP1 |
| CFTR | Cystic fibrosis | Overexpression in airway epithelial cells |
Prostaglandin Receptors in Inflammatory and Autoimmune Diseases
Prostaglandin receptor activity is critically involved in inflammatory and autoimmune conditions. EP4 expression on Th17 cells correlates with high disease activity in ankylosing spondylitis, suggesting a role in pathogenesis. CRTH2 (DP2) on B cells is essential for IL-1β production during experimental autoimmune encephalomyelitis, highlighting its contribution to neuroinflammation. DP1 and DP2 antagonists are investigated for airway inflammation in asthma.
Cardiovascular Implications of Prostaglandin Receptor Activity
Impaired prostaglandin E1/I2 receptor activity on platelets has been observed in acute ischemic heart disease, indicating a role in cardiovascular pathology. The IP receptor mediates vasodilation and inhibits platelet aggregation, and its dysfunction may contribute to thrombotic events. Targeting these receptors could offer therapeutic benefits.
Prostaglandin Receptors in Airway and Epithelial Function
Prostaglandin signaling activates CFTR-mediated chloride transport in airway epithelium, which is important for mucociliary clearance. Dysregulation of this pathway may exacerbate respiratory diseases such as asthma and cystic fibrosis. DP2 antagonists like fevipiprant aim to modulate these responses.
From prostaglandin receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does receptor X mediate PGD2-induced cAMP? | Knockout of PTGDR in HEK293 cells |
| What is the role of EP4 in Th17 differentiation? | Point mutation of PTGER4 in primary T cells |
| Can a humanized DP1 receptor be used for drug testing? | Knock-in of human PTGDR in mice |
| Where is CRTH2 localized during EAE? | Tagged knock-in of CRTH2 with GFP |
| Does overexpression of IP receptor protect against thrombosis? | Overexpression of PTGIR in platelets |
| What genes are regulated by prostaglandin signaling? | CRISPR library screening in inflammatory cells |
How to Study the prostaglandin receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of receptor function | Identifying essential receptors in signaling |
| Point mutation | Effect of specific amino acid changes | Mapping ligand-binding residues |
| Knock-in | Replacement of endogenous gene | Humanizing receptors for drug testing |
| Overexpression | Gain of function | Studying constitutive activity |
| cAMP assay | Intracellular cAMP levels | Measuring Gs-coupled receptor activity |
| β-arrestin recruitment | Receptor desensitization | Evaluating biased agonism |
| Cryo-EM | 3D structure of receptor-ligand complex | Structure-based drug design |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate prostaglandin receptor activity. For example, screening for regulators of PGD2-induced cAMP production can reveal novel signaling components.
Biochemical Assays for Receptor Activity
Ligand binding assays, cAMP measurements, and β-arrestin recruitment assays are used to quantify prostaglandin receptor activity. These methods are essential for characterizing receptor pharmacology and mutant variants.
Structural Biology and Imaging
Cryo-EM and X-ray crystallography provide atomic-level insights into ligand recognition and receptor activation, as demonstrated for DP1. Fluorescence microscopy can visualize receptor internalization and trafficking.
Animal Models and Disease Phenotyping
Knockout and transgenic mice for prostaglandin receptors are used to study disease phenotypes, such as EAE and asthma models. These models help validate therapeutic targets.
How CRISPR Can Be Used to Study GO:0004955 prostaglandin receptor activity
Knockout
CRISPR knockout of prostaglandin receptor genes (e.g., PTGDR, PTGER4) in cell lines or primary cells abolishes receptor function, enabling studies of downstream signaling and disease mechanisms.
Point Mutation
Introducing point mutations in receptor genes allows researchers to dissect the contribution of specific residues to ligand binding, G protein coupling, and desensitization.
Knock-in
Knock-in of human receptor genes into mouse models or tagging endogenous receptors with fluorescent proteins facilitates in vivo imaging and drug testing.
Overexpression
Overexpression of prostaglandin receptors in cell lines can amplify signaling for biochemical assays and screening of agonists/antagonists.
How EDITGENE Supports prostaglandin receptor activity Research
Researchers studying prostaglandin receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, disease pathogenesis, or drug response. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell and animal models, accelerating functional validation and therapeutic development.
Contact EDITGENE today to design your custom CRISPR model for prostaglandin receptor activity research.
Frequently Asked Questions About prostaglandin receptor activity
What is prostaglandin receptor activity?
Prostaglandin receptor activity (GO:0004955) is the molecular function of binding to a prostaglandin molecule and initiating a change in cell activity, typically through G protein-coupled receptors.
What genes are involved in prostaglandin receptor activity?
Key genes include PTGDR (DP1), PTGDR2 (CRTH2), PTGER1-4 (EP1-EP4), PTGFR (FP), PTGIR (IP), and TBXA2R (TP), which encode receptors for various prostaglandins.
How is prostaglandin receptor activity regulated?
It is regulated by receptor expression levels, desensitization via GRK-mediated phosphorylation and β-arrestin recruitment, and ligand availability through cyclooxygenases.
What diseases are associated with prostaglandin receptor activity?
Diseases include ankylosing spondylitis, asthma, acute ischemic heart disease, and autoimmune neuroinflammation.
What are the major prostaglandin receptors?
Major receptors are DP1, DP2, EP1-EP4, FP, IP, and TP, each with distinct ligand specificity and signaling pathways.
How can CRISPR be used to study prostaglandin receptor activity?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to dissect receptor function and signaling in vitro and in vivo.
What is the role of DP1 receptor?
DP1 (PTGDR) is a Gs-coupled receptor for PGD2 that mediates allergic inflammation and is a target for therapeutic intervention.
What is CRTH2?
CRTH2 (DP2) is a Gi-coupled receptor for PGD2 that regulates Th2 and B cell responses and is implicated in asthma and autoimmune diseases.
How does prostaglandin signaling affect CFTR?
Prostaglandin signaling activates CFTR-mediated chloride transport in airway epithelium, which is important for mucociliary clearance.
What experimental models are available for prostaglandin receptor research?
Models include CRISPR knockout cell lines, point mutant mice, humanized knock-in mice, and overexpression systems, as well as biochemical assays for cAMP and β-arrestin recruitment.
Conclusion
Prostaglandin receptor activity (GO:0004955) is a fundamental molecular function that mediates the diverse effects of prostaglandins in health and disease. Understanding its mechanisms, key genes, and regulatory networks is essential for developing targeted therapies for inflammatory, cardiovascular, and autoimmune disorders. Advanced CRISPR-based models and biochemical assays provide powerful tools to interrogate this activity and accelerate drug discovery.
References
- 1. Xu J et al.. 2025. Molecular basis for ligand recognition and receptor activation of the prostaglandin D2 receptor DP1.. Proc Natl Acad Sci U S A 122(22):e2501902122 PMID: 40440061
- 2. Klasen C et al.. 2019. Prostaglandin receptor EP4 expression by Th17 cells is associated with high disease activity in ankylosing spondylitis.. Arthritis Res Ther 21(1):159 PMID: 31253169
- 3. Davoudinasab B et al.. 2025. Structural insights into the mechanism of activation and inhibition of the prostaglandin D2 receptor 1.. Nat Commun 16(1):8944 PMID: 41062467
- 4. Santini G et al.. 2016. Investigational prostaglandin D2 receptor antagonists for airway inflammation.. Expert Opin Investig Drugs 25(6):639-52 PMID: 27094922
- 5. Kahn NN et al.. 1990. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.. Circ Res 66(4):932-40 PMID: 2156636
- 6. Shaughnessy CA et al.. 2022. Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway.. Am J Physiol Lung Cell Mol Physiol 322(3):L305-L314 PMID: 35020527
- 7. Brightling C et al.. 2021. The pharmacology of the prostaglandin D(2) receptor 2 (DP(2)) receptor antagonist, fevipiprant.. Pulm Pharmacol Ther 68:102030 PMID: 33826946
- 8. Liu J et al.. 2025. CRTH2 is critical for IL-1β-producing B cells during experimental autoimmune encephalomyelitis in mice via p38 signaling.. J Neuroinflammation 22(1):201 PMID: 40781334
